Tuesday, November 30, 2021

Indian Immunologicals

Govt lauds Indian Immunologicals for producing Covid-19 vaccine drug substance in record time

IL quickly responded to the nation’s call and the request of the Central Government, to partner with Bharat Biotech International Limited (BBIL) in April 2021 to produce a Covaxin drug substance.

Indian Immunologicals ramping up Covaxin drug substance production

Output of Covaxin drug substance will be adequate for 3 to 4 million doses a month and from December it will increase to 10 million doses a month

Exploring all options to procure enough vaccines: KTR

Task Force also discussed with them various alternatives to drugs that are in high demand like Remdesivir

Indian Immunologicals to add capacity with Rs 150-cr investment in Telangana

Hyderabad-headquartered biologicals company setting up new viral antigen plant at Karkapatla in Telangana to cater to viral vaccines and opens new sterile filling facility

Latest News

- Advertisement -